Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Exprimo

Exprimo
2002 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provides consultancy services to all stages of pharmaceutical development. The company primarily focuses its activities towards the application of quantitative, model-based approaches such as modelling & simulations, PK/PD modelling, Drug-disease modelling. Its servises includes population pharmacokinetics, paediatrics, consulting and advice with respect to all aspects of modelling during drug development and customized training.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Decision/Risk Analysis
Other Healthcare Technology Systems
Parent Company
Primary Office
  • Generaal de Wittelaan 19A b5
  • 2800 Mechelen
  • Belgium

+32 015 00 00 00

Exprimo Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Exprimo‘s full profile, request access.

Request full access to PitchBook

Exprimo Executive Team (3)

Name Title Board
Seat
Contact
Info
Eric Snoeck Ph.D Co-Founder & Managing Director
Per Gisleskog Co-Founder & Principal Consultant
Philippe Jacqmin Co-Founder & Director